These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 32519649)

  • 21. Meta-analysis: Cysticidal drugs for neurocysticercosis: albendazole and praziquantel.
    Del Brutto OH; Roos KL; Coffey CS; García HH
    Ann Intern Med; 2006 Jul; 145(1):43-51. PubMed ID: 16818928
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Therapy for neurocysticercosis.
    Takayanagui OM
    Expert Rev Neurother; 2004 Jan; 4(1):129-39. PubMed ID: 15853623
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neurocysticercosis: migration and proliferation of cysticercus in a CSF valve.
    Djientcheu VD; Zona G; Rilliet B
    Br J Neurosurg; 2000 Apr; 14(2):135-7. PubMed ID: 10889887
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy of Combination Therapy of Albendazole and Praziquantel vs Albendazole Monotherapy in Children With Persistent Neurocysticercosis: A Randomized Controlled Trial.
    Singh K; Saini AG; Khandelwal N; Singhi P
    J Child Neurol; 2022 Apr; 37(5):366-372. PubMed ID: 35213246
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical analysis of 52 cases of neurocysticercosis.
    Chaoshuang L; Zhixin Z; Xiaohong W; Zhanlian H; Zhiliang G
    Trop Doct; 2008 Jul; 38(3):192-4. PubMed ID: 18628562
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neurocysticercosis: an unusual cause of seizure in the New Zealand setting.
    Pybus M; Heron P
    J Paediatr Child Health; 2012 Mar; 48(3):E119-21. PubMed ID: 21276113
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Natural History of Treated Subarachnoid Neurocysticercosis.
    Nash TE; O'Connell EM; Hammoud DA; Wetzler L; Ware JM; Mahanty S
    Am J Trop Med Hyg; 2020 Jan; 102(1):78-89. PubMed ID: 31642423
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Relationship between cysticercosis and epilepsy.
    Monteiro L; Lopes J; Martins da Silva A
    Epilepsia; 1999 Oct; 40(10):1464-5. PubMed ID: 10528946
    [No Abstract]   [Full Text] [Related]  

  • 29. Subarachnoidal Neurocysticercosis non-responsive to cysticidal drugs: a case series.
    Cárdenas G; Carrillo-Mezo R; Jung H; Sciutto E; Hernandez JL; Fleury A
    BMC Neurol; 2010 Mar; 10():16. PubMed ID: 20202200
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Etanercept to Control Inflammation in the Treatment of Complicated Neurocysticercosis.
    Nash TE; Ware JM; Coyle CM; Mahanty S
    Am J Trop Med Hyg; 2019 Mar; 100(3):609-616. PubMed ID: 30608049
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Routine drug and food interactions during antihelminthic treatment of neurocysticercosis: a reason for the variable efficacy of albendazole and praziquantel?
    Romo ML; Carpio A; Kelvin EA
    J Clin Pharmacol; 2014 Apr; 54(4):361-7. PubMed ID: 24443292
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacokinetic variability of anthelmintics: implications for the treatment of neurocysticercosis.
    Jung-Cook H
    Expert Rev Clin Pharmacol; 2012 Jan; 5(1):21-30. PubMed ID: 22142156
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Radiological evolution of porcine neurocysticercosis after combined antiparasitic treatment with praziquantel and albendazole.
    Cangalaya C; Bustos JA; Calcina J; Vargas-Calla A; Mamani J; Suarez D; Arroyo G; Gonzalez AE; Chacaltana J; Guerra-Giraldez C; Mahanty S; Nash TE; García HH;
    PLoS Negl Trop Dis; 2017 Jun; 11(6):e0005624. PubMed ID: 28575043
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Resolution of urticarial vasculitis after treatment of neurocysticercosis.
    Shaigany S; Dabela E; Teich AF; Husain S; Grossman ME
    J Am Acad Dermatol; 2015 Jan; 72(1):e32-3. PubMed ID: 25497947
    [No Abstract]   [Full Text] [Related]  

  • 35. Single-day praziquantel versus 1-week albendazole for neurocysticercosis.
    Del Brutto OH; Campos X; Sánchez J; Mosquera A
    Neurology; 1999 Mar; 52(5):1079-81. PubMed ID: 10102436
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inflammatory aneurysm and neurocysticercosis: further evidence for a causal relationship? Case report.
    Huang PP; Choudhri HF; Jallo G; Miller DC
    Neurosurgery; 2000 Aug; 47(2):466-7; discussion 467-8. PubMed ID: 10942024
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prolonged perilesional edema after treatment of parenchymal neurocysticercosis: methotrexate as a corticosteroid-sparing agent.
    Keiser PB; Nash TE
    Clin Infect Dis; 2003 May; 36(10):e122-6. PubMed ID: 12746791
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Treatment of neurocysticercosis: a review].
    Nogales-Gaete J; Arriagada C; Salinas R
    Rev Med Chil; 2006 Jun; 134(6):789-96. PubMed ID: 17130956
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy of a 3-day course of albendazole treatment in patients with a single neurocysticercosis cyst.
    Bustos JA; Pretell EJ; Llanos-Zavalaga F; Gilman RH; Del Brutto OH; Garcia HH;
    Clin Neurol Neurosurg; 2006 Feb; 108(2):193-4. PubMed ID: 16412842
    [No Abstract]   [Full Text] [Related]  

  • 40. Neurocysticercosis in Wisconsin: 3 cases and a review of the literature.
    Naddaf E; Seeger SK; Stafstrom CE
    WMJ; 2014 Apr; 113(2):74-8; quiz 79. PubMed ID: 24908903
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.